Skip to main content
SpringerLink
Log in

Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma (PCBCL) have rarely been reviewed, due to the rarity and pathologic obscurity of this disease. We reviewed 21 patients who were pathologically diagnosed with PCBCL from Samsung Medical Center’s lymphoma cohort, following the WHO–EORTC classification system: primary cutaneous follicle-center lymphoma (PCFCL), primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous diffuse large B-cell lymphoma, leg type (PCLBCL, LT), and cutaneous diffuse large B-cell lymphoma, other (PCDLBCL, other). Of 2831 B-cell lymphoma cases, PCBCL comprised only 0.74 % of cases (N = 21, eight PCLBCL, LT (0.28 %), 10 PCMZL (0.35 %), two PCDLBCL, other (0.06 %), and one PCFCL (0.03 %)). Eighteen of 21 patients received treatment for PCBCL (12 chemotherapy alone, three radiotherapy alone, three chemotherapy following radiotherapy) and complete response (CR) was observed in 17 patients. The median progression-free survival was 44 months [95 % confidence interval (CI): 11–61 months]. Two patients had died at the time of analysis, with a median follow-up duration of 85 months [95 % confidence interval (CI): 55–118 months]. PCBCL cases in this study have a higher proportion of disseminated PCMZL and PCLBCL, LT, and excellent outcomes were observed with chemotherapy, including R-CHOP or R-CVP irrespective of staging and pathologic subtype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jaffe ES, Harris NL, Stein H, Isaacson PG. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood. 2008;112:4384–99.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO–EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768–85.

    Article  CAS  PubMed  Google Scholar 

  3. Garcia CF, Weiss LM, Warnke RA, Wood GS. Cutaneous follicular lymphoma. Am J Surg Pathol. 1986;10:454–63.

    Article  CAS  PubMed  Google Scholar 

  4. Pimpinelli N, Santucci M, Bosi A, Moretti S, Vallecchi C, Messori A, et al. Primary cutaneous follicular centre-cell lymphoma–a lymphoproliferative disease with favourable prognosis. Clin Exp Dermatol. 1989;14:12–9.

    Article  CAS  PubMed  Google Scholar 

  5. Santucci M, Pimpinelli N, Arganini L. Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases. Cancer. 1991;67:2311–26.

    Article  CAS  PubMed  Google Scholar 

  6. Grange F, Hedelin G, Joly P, Beylot-Barry M, D’Incan M, Delaunay M, et al. Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sezary syndrome. The French Study Group on Cutaneous Lymphomas. Blood. 1999;93:3637–42.

    CAS  PubMed  Google Scholar 

  7. Vermeer MH, Geelen FA, van Haselen CW, van Voorst Vader PC, Geerts ML, van Vloten WA, et al. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group. Arch Dermatol. 1996;132:1304–8.

    Article  CAS  PubMed  Google Scholar 

  8. Grange F, Petrella T, Beylot-Barry M, Joly P, D’Incan M, Delaunay M, et al. Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas. Blood. 2004;103:3662–8.

    Article  CAS  PubMed  Google Scholar 

  9. Zinzani PL, Quaglino P, Pimpinelli N, Berti E, Baliva G, Rupoli S, et al. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol. 2006;24:1376–82.

    Article  PubMed  Google Scholar 

  10. Smith BD, Glusac EJ, McNiff JM, Smith GL, Heald PW, Cooper DL, et al. Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems. J Clin Oncol. 2004;22:634–9.

    Article  PubMed  Google Scholar 

  11. Rijlaarsdam JU, Toonstra J, Meijer OW, Noordijk EM, Willemze R. Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. J Clin Oncol. 1996;14:549–55.

    CAS  PubMed  Google Scholar 

  12. Bekkenk MW, Vermeer MH, Geerts ML, Noordijk EM, Heule F, van Voorst Vader PC, et al. Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients. J Clin Oncol. 1999;17:2471–8.

    CAS  PubMed  Google Scholar 

  13. Eich HT, Eich D, Micke O, Suttzer H, Casper C, Krieg T, et al. Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma. Int J Radiat Oncol Biol Phys. 2003;55:899–906.

    Article  PubMed  Google Scholar 

  14. Senff NJ, Hoefnagel JJ, Neelis KJ, Vermeer MH, Noordijk EM, Willemze R. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO–EORTC classification. Arch Dermatol. 2007;143:1520–6.

    Article  PubMed  Google Scholar 

  15. Sokol L, Naghashpour M, Glass LF. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management. Cancer Control. 2012;19:236–44.

    PubMed  Google Scholar 

  16. Bessell EM, Humber CE, O’Connor S, English JS, Perkins W, Dickinson PD, et al. Primary cutaneous B-cell lymphoma in Nottinghamshire UK: prognosis of subtypes defined in the WHO–EORTC classification. Br J Dermatol. 2012;167:1118–23.

    Article  CAS  PubMed  Google Scholar 

  17. Willemze R. Primary cutaneous B-cell lymphoma: classification and treatment. Curr Opin Oncol. 2006;18:425–31.

    Article  PubMed  Google Scholar 

  18. Kempf W, Denisjuk N, Kerl K, Cozzio A, Sander C. Primary cutaneous B-cell lymphomas. J Dtsch Dermatol Ges. 2012;10:12–22 quiz 23.

    PubMed  Google Scholar 

  19. Khamaysi Z, Ben-Arieh Y, et al. The applicability of the new WHO–EORTC classification of primary cutaneous lymphomas to a single referral center. Am J Dermatopathol. 2008;30(1):37–44.

    Article  PubMed  Google Scholar 

  20. Jenni D, Karpova MB, et al. Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre. Br J Dermatol. 2011;164(5):1071–7.

    Article  CAS  PubMed  Google Scholar 

  21. Bradford PT, Devesa SS, et al. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113(21):5064–73.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Fujita A, Hamada T, et al. Retrospective analysis of 133 patients with cutaneous lymphomas from a single Japanese medical center between 1995 and 2008. J Dermatol. 2011;38(6):524–30.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, Korea

    Moon Jin Kim, Chi Hoon Maeng, Hyun Ae Jung, Jung Yong Hong, Moon Ki Choi, Seok Jin Kim & Won Seog Kim

  2. Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

    Min Eui Hong & Young Hyeh Ko

Authors
  1. Moon Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Min Eui Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chi Hoon Maeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hyun Ae Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jung Yong Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Moon Ki Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Seok Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Young Hyeh Ko
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Won Seog Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Won Seog Kim.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, M.J., Hong, M.E., Maeng, C.H. et al. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea. Int J Hematol 101, 273–278 (2015). https://doi.org/10.1007/s12185-014-1728-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-014-1728-2

Keywords

Search

Navigation